Literature DB >> 1708468

Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain.

G M Halliday1, W P Gai, W W Blessing, L B Geffen.   

Abstract

We have employed immunohistochemical and computerized morphometric procedures to study substance P-containing neurons in the tegmentum of adult humans. An estimated 192,500 +/- 40,500 substance P-containing neurons were found in three main cytoarchitectural regions: the mesencephalic reticular formation, the central gray, and the pontine reticular formation. The morphology of the immunoreactive neurons varied according to the region in which they were found. On the basis of size alone two types of substance P-containing neurons, large and small, were readily distinguishable by eye and measurement. Within each of the three main regions it was possible to distinguish distinct subgroups using cell size, morphology and position. Large neurons were concentrated in the caudal midbrain (pedunculopontine tegmental nuclei), in the oral pontine reticular nucleus and in the lateral dorsal tegmental nucleus. In contrast, small neurons were concentrated in the rostral mesencephalic reticular formation (cuniform nuclei). Both small and large neurons were found in the midbrain and pontine raphe nuclei. In addition, small neurons were concentrated in discrete midline regions (the periaqueductal gray, the tegmental nuclei of the pontine central gray, and the interpeduncular nucleus). The findings suggest that the majority of neurons in the brainstem tegmental nuclei previously identified as cholinergic also contain substance P in humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708468     DOI: 10.1016/0306-4522(90)90223-q

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Emotional state affects gait initiation in individuals with Parkinson's disease.

Authors:  Kelly M Naugle; Chris J Hass; Dawn Bowers; Christopher M Janelle
Journal:  Cogn Affect Behav Neurosci       Date:  2012-03       Impact factor: 3.282

2.  Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.

Authors:  M Gomez-Gallego; E Fernandez-Villalba; A Fernandez-Barreiro; M T Herrero
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

Review 3.  The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Authors:  Nick Pantaleo; Wayne Chadwick; Sung-Soo Park; Liyun Wang; Yu Zhou; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

4.  The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.

Authors:  Kay Seidel; Josefine Mahlke; Sonny Siswanto; Reijko Krüger; Helmut Heinsen; Georg Auburger; Mohamed Bouzrou; Lea T Grinberg; Helmut Wicht; Horst-Werner Korf; Wilfred den Dunnen; Udo Rüb
Journal:  Brain Pathol       Date:  2014-09-12       Impact factor: 6.508

5.  Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse.

Authors:  Christopher A Gadd; Patricia Murtra; Carmen De Felipe; Stephen P Hunt
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

6.  Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.

Authors:  R M Villalba; T Wichmann; Y Smith
Journal:  Brain Struct Funct       Date:  2013-03-19       Impact factor: 3.270

7.  Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease.

Authors:  Erik Ziegler; Maud Rouillard; Elodie André; Tim Coolen; Johan Stender; Evelyne Balteau; Christophe Phillips; Gaëtan Garraux
Journal:  Neuroimage       Date:  2014-06-20       Impact factor: 6.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.